1. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Gurevich EV, Gainetdinov RR, Gurevich VV (2016) Pharmacol Res : 1-16
    › Primary publication · 27178731 (PubMed) · PMC5079267 (PubMed Central)
  2. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways. Hu J, Stern M, Gimenez LE, Wanka L, Zhu L, Rossi M, Meister J, Inoue A, Beck-Sickinger AG, Gurevich VV, Wess J (2016) J Biol Chem 291(15): 7809-20
    › Primary publication · 26851281 (PubMed) · PMC4824988 (PubMed Central)
  3. Using Bioluminescence Resonance Energy Transfer (BRET) to Characterize Agonist-Induced Arrestin Recruitment to Modified and Unmodified G Protein-Coupled Receptors. Donthamsetti P, Quejada JR, Javitch JA, Gurevich VV, Lambert NA (2015) Curr Protoc Pharmacol : 2.14.1-2.14.14
    › Primary publication · 26331887 (PubMed) · PMC4583203 (PubMed Central)
  4. The rhodopsin-arrestin-1 interaction in bicelles. Chen Q, Vishnivetskiy SA, Zhuang T, Cho MK, Thaker TM, Sanders CR, Gurevich VV, Iverson TM (2015) Methods Mol Biol : 77-95
    › Primary publication · 25697518 (PubMed) · PMC4520306 (PubMed Central)
  5. Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor. Chang SD, Mascarella SW, Spangler SM, Gurevich VV, Navarro HA, Carroll FI, Bruchas MR (2015) Mol Pharmacol 88(3): 502-11
    › Primary publication · 26134494 (PubMed) · PMC4551045 (PubMed Central)
  6. Influence of Arrestin on the Photodecay of Bovine Rhodopsin. Chatterjee D, Eckert CE, Slavov C, Saxena K, F├╝rtig B, Sanders CR, Gurevich VV, Wachtveitl J, Schwalbe H (2015) Angew Chem Int Ed Engl 54(46): 13555-60
    › Primary publication · 26383645 (PubMed) · PMC4685475 (PubMed Central)
  7. How genetic errors in GPCRs affect their function: Possible therapeutic strategies. Stoy H, Gurevich VV (2015) Genes Dis 2(2): 108-132
    › Primary publication · 26229975 (PubMed) · PMC4516391 (PubMed Central)
  8. GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domain. Ahmed MR, Bychkov E, Li L, Gurevich VV, Gurevich EV (2015) Sci Rep : 10920
    › Primary publication · 26043205 (PubMed) · PMC4455246 (PubMed Central)
  9. G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs). Li L, Homan KT, Vishnivetskiy SA, Manglik A, Tesmer JJ, Gurevich VV, Gurevich EV (2015) J Biol Chem 290(17): 10775-90
    › Primary publication · 25770216 (PubMed) · PMC4409243 (PubMed Central)
  10. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro. Inagaki S, Ghirlando R, Vishnivetskiy SA, Homan KT, White JF, Tesmer JJ, Gurevich VV, Grisshammer R (2015) Biochemistry 54(28): 4320-9
    › Primary publication · 26120872 (PubMed) · PMC4512254 (PubMed Central)